Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Depressive mood symptoms associated with ovarian suppression.

Warnock JK, Bundren JC, Morris DW.

Fertil Steril. 2000 Nov;74(5):984-6.

PMID:
11056245
2.

Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.

Warnock JK, Bundren JC, Morris DW.

Biol Psychiatry. 1998 Mar 15;43(6):464-5.

PMID:
9532352
3.

Depressive symptoms associated with gonadotropin-releasing hormone agonists.

Warnock JK, Bundren JC, Morris DW.

Depress Anxiety. 1998;7(4):171-7. Review.

PMID:
9706454
4.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
5.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
6.

Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.

Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS.

Hum Psychopharmacol. 2005 Mar;20(2):97-104.

PMID:
15641125
7.

Preventing depression after stroke: Results from a randomized placebo-controlled trial.

Almeida OP, Waterreus A, Hankey GJ.

J Clin Psychiatry. 2006 Jul;67(7):1104-9.

PMID:
16889454
8.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
9.

The effects of sertraline on severe tinnitus suffering--a randomized, double-blind, placebo-controlled study.

Zöger S, Svedlund J, Holgers KM.

J Clin Psychopharmacol. 2006 Feb;26(1):32-9.

PMID:
16415703
10.

Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.

Warnock JK, Bundren JC.

Psychopharmacol Bull. 1997;33(2):311-6.

PMID:
9230649
11.

Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

Ravindran AV, Guelfi JD, Lane RM, Cassano GB.

J Clin Psychiatry. 2000 Nov;61(11):821-7.

PMID:
11105734
13.

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D.

J Clin Psychiatry. 2001 Jan;62(1):24-9.

PMID:
11235924
14.

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.

Lucas M, Asselin G, Mérette C, Poulin MJ, Dodin S.

Am J Clin Nutr. 2009 Feb;89(2):641-51. doi: 10.3945/ajcn.2008.26749. Epub 2008 Dec 30.

15.

A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.

Ashman TA, Cantor JB, Gordon WA, Spielman L, Flanagan S, Ginsberg A, Engmann C, Egan M, Ambrose F, Greenwald B.

Arch Phys Med Rehabil. 2009 May;90(5):733-40. doi: 10.1016/j.apmr.2008.11.005.

PMID:
19406291
16.

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.

Brady KT, Clary CM.

Compr Psychiatry. 2003 Sep-Oct;44(5):360-9.

PMID:
14505296
17.

Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.

Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R.

J Clin Psychopharmacol. 2003 Dec;23(6):553-62.

PMID:
14624185
19.
20.

Supplemental Content

Support Center